Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness

Sheba and Vidac
CAR T-cell therapy is a revolutionary cancer treatment involving the extraction and genetic modification of a patient's T-cells to produce chimeric antigen receptors (CARs). These engineered T-cells are reintroduced to the patient’s body to attack tumor cells.

While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few months and hinder the therapy’s effectiveness, Sheba completes the entire treatment process in less than two weeks thanks to its specialized in-house laboratory. However, not all patients respond to the treatment, with a major hurdle being the Warburg effect, a phenomenon that triggers hyperglycolysis within the tumor microenvironment (TME), which is unfavorable for CAR T-cell therapy effectiveness.

Recently, Sheba and Vidac Pharma partnered to tackle this issue, collaborating on a study that evaluates a novel drug with the potential to reverse the Warburg effect, thereby preventing the lactate-producing hyperglycolysis from compromising treatment efficacy. The new research will be headed by Dr. Elad Jacoby, Head of Pediatric Cell Therapy at Sheba’s Safra Children’s Hospital, and Dr. Yuval Sagiv, CTO of Vidac Pharma. 

This pivotal collaboration marks a significant stride in blood cancer treatment, offering patients across the globe new hope. Stay tuned for updates on the progress of the study.

A pregnant woman smiling while talking to obstetricians and gynecologists at a maternity center.
Navigating IVF Treatment at Sheba: Hailey's Journey to Motherhood
Navigating complex and uncertain emotions is a common experience for individuals undergoing IVF treatment. Hailey, a determined woman with a desire to embrace motherhood, embarked…
Read More
Hands holding a purple ribbon for cancer day with the 'World Cancer Day' text on the left side.
World Cancer Day: Sheba’s Dedication to Cancer Care
February 4th marks World Cancer Day, a day of global observance and, most importantly, a golden opportunity to raise awareness of this deadly and multifaceted…
Read More
Doctors looking at brain x-rays in a futuristic sci-fi way using VR headsets.
Revolutionizing Care: AIDOC's Impact in Sheba's Critical Treatments
Following the attacks on October 7th, Sheba saw a steady flow of patients admitted into the ICU with an array of horrific injuries. An array…
Read More